Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007761 · ClinicalTrials.gov registry record · Phase 3
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 382
- Enrollment target
NCT00007761: Completed Phase 3 study, sponsored by US Department of Veterans Affairs.
NCT00007761 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 382 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007761, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 382 participants
- Enrollment target
Study Summary
Based on highly promising preliminary data, it is proposed to conduct a multi-site randomized controlled trial of a high-intensity ambulatory treatment program for bipolar disorder against standard office-based, physician-centered care. The major characteristics of this program are that it emphasizes (1) aggressive guideline-driven pharmacotherapy, (2) continuity of care with identified primary mental health nurse clinicians supported by psychiatrist back-up, and (3) patient education to improve treatment alliance and illness management skills.
Interventions
- BEHAVIORAL Bipolar Disorder Program
- BEHAVIORAL Usual (psychiatric) Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 1997-07 |
| Phase | Phase 3 |
What the finished NCT00007761 record still lists
NCT00007761 is an interventional study that assigns participants to a tested intervention. The registered 382 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 2 interventions - of which Bipolar Disorder Program is the first listed.
NCT00007761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00007761 about?
NCT00007761 is a clinical study titled "Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.". Based on highly promising preliminary data, it is proposed to conduct a multi-site randomized controlled trial of a high-intensity ambulatory treatment program for bipolar disorder against standard office-based, physician-centered care. The major characteristics of this program are that it emphasize...
What is the current status of trial NCT00007761?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 382 participants. The study started on 1997-07.
What interventions are being tested in trial NCT00007761?
The interventions under investigation include: Bipolar Disorder Program (BEHAVIORAL), Usual (psychiatric) Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00007761?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00007761's enrollment target sits among peer trials
382 978th of 2000 higher than 1,019 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia